IN BRIEF: Cambridge Cognition raises cash to fund next stage of growth
Cambridge Cognition Holdings PLC - brain health software provider based in Cambridge, England - Plans to raise a minimum of £2.5 million through a £1.5 million placing to existing institutional investors and a £1.0 million subscription by certain investors at 35.0 pence per share. The placing will be via an accelerated bookbuild process. In addition, the company plans to raise up to £500,000 via a retail offer at the same price. Proceeds will fund the next phase of development, focused on expanding adoption of its digital cognitive assessment platform within healthcare and clinical settings and progressing towards a more ‘scalable, commercially focused business model’. Cambridge Cognition says 2026 has started well and it already has visibility over £10 million of revenue and continues to trade in line with market expectations. But it adds the investments above will mean ‘significantly increasing the cost base, and therefore losses, over the next two years’. The firm expects to see the benefits of the investment programmes feed through to additional revenue growth beyond existing plans from 2028.
Current stock price: 34.40 pence
12-month change: down 7.0%
Copyright 2026 Alliance News Ltd. All Rights Reserved.